| Literature DB >> 32298342 |
EunBi Kim1, Myeongsun Kim1, Hyung-Kyoon Choi1.
Abstract
Lemna species have been used in the food, feed, and pharmaceutical industries, as they are inexpensive sources of proteins, starches, and fatty acids. In this study, we treated L. paucicostata with different concentrations (0.05, 0.1, 0.2, 0.5, or 1 mM) of ethephon. The total dry weight decreased in all ethephon-treated groups compared to the control group. We also investigated the alteration of metabolic profiles induced by ethephon treatment by using gas chromatography-mass spectrometry. This analysis identified 48 metabolites, and the relative levels of most of alcohols, amino acids, fatty acids, and phenols increased by the ethephon treatment, whereas levels of organic acids and sugars decreased. Among these, the highest production of γ-aminobutyric acid (GABA, 5.041 ± 1.373 mg/L) and ferulic acid (0.640 ± 0.071 mg/L) was observed in the 0.5 mM and the 0.2 mM ethephon treatment groups, respectively. These results could be useful for large-scale culture of L. paucicostata with enhanced GABA and ferulic acid content for utilization in the food, feed, cosmetic, and pharmaceutical industries.Entities:
Year: 2020 PMID: 32298342 PMCID: PMC7162458 DOI: 10.1371/journal.pone.0231652
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Effects of various ethephon concentrations on total dry weight of L. paucicostata.
Vertical bars indicate mean values and error bars represent the standard deviation (n = 3) of each treatment group. An asterisk indicates significant differences (p < 0.05) between control and treated groups based on Student´s t-test.
Peak assignment and identification of various metabolites in L. paucicostata obtained by GC-MS analysis.
| NO. | Compound | RT | TMS | Ion fragment (m/z) |
|---|---|---|---|---|
| 1 | Glycerol | 13.40 | 3 | 103, 117, |
| 2 | Glycerol-3-phosphate | 27.95 | 4 | 103, 299, |
| 3 | Myo-inositol | 39.28 | 6 | 191, 217, |
| 4 | Myo-inositol phosphate | 47.53 | 7 | 217, 299, |
| 5 | Alanine | 8.80 | 2 | 100, |
| 6 | β-Alanine | 17.26 | 3 | 86, |
| 7 | Asparagine | 22.21 | 2 | 100, 116, 130, |
| 24.77 | 3 | |||
| 8 | Aspartic acid | 19.77 | 3 | 100, 202, 218, |
| 9 | Cysteine | 20.84 | 3 | 100, 132, |
| 10 | Glutamic acid | 23.10 | 3 | 128, 156, 218, |
| 11 | Glutamine | 28.26 | 3 | 128, |
| 12 | Glycine | 14.17 | 3 | 86, 133, |
| 13 | Histidine | 32.88 | 3 | |
| 14 | Isoleucine | 13.85 | 3 | |
| 15 | Lysine | 33.16 | 4 | 128, 156, 230, |
| 16 | Proline | 13.94 | 2 | 99, 133, |
| 17 | Pyroglutamic acid | 19.64 | 2 | |
| 18 | Serine | 12.90 | 2 | 57, 103, |
| 15.66 | 3 | 100, 188, | ||
| 19 | Threonine | 16.30 | 3 | 101, 117, |
| 20 | Tryptophan | 42.78 | 3 | 100, |
| 21 | Valine | 8.44 | 1 | 55, |
| 11.79 | 2 | 100, | ||
| 22 | Glycerol monostearate | 54.12 | 2 | 57, 129, 205, |
| 23 | Linoleic acid | 42.95 | 1 | 81, 117, 129, |
| 24 | α-Linoleic acid | 43.10 | 1 | |
| 25 | Palmitic acid | 37.98 | 1 | |
| 26 | Stearic acid | 43.84 | 1 | |
| 27 | Citric acid | 29.82 | 4 | |
| 28 | Erythronic acid | 20.49 | 4 | 117, 205, 220, |
| 29 | Fumaric acid | 15.45 | 2 | 115, 133, 143, |
| 30 | Glyceric acid | 14.87 | 3 | 103, 133, |
| 31 | 3-Hydroxy-3-methyl glutaric acid | 22.44 | 3 | 115, 231, |
| 32 | 2-Keto-D-gluconic acid | 18.56 | 4 | 103, 117, 205, |
| 33 | Malic acid | 18.83 | 3 | 101, 175, 190, |
| 34 | Succinic acid | 14.47 | 2 | 55, 129, 172, |
| 35 | Caffeic acid | 40.93 | 3 | 191, |
| 36 | p-Coumaric acid | 33.70 | 2 | |
| 37 | Ferulic acid | 39.41 | 2 | 249, 308, 323, |
| 38 | Fructose | 29.29 | 5 | 129, |
| 31.48 | 5 (MEOX) | |||
| 39 | Galactose | 32.47 | 5 | 129, 191, |
| 40 | Glucose | 32.11 | 5 | 129, 191, |
| 32.27 | 5 (MEOX) | 160, 205, 217, | ||
| 41 | Sucrose | 51.81 | 8 | 217, 271, |
| 42 | γ-Aminobutyric acid (GABA) | 20.01 | 3 | 86, |
| 43 | Phosphoric acid | 13.28 | 3 | 133, 211, |
| 44 | Serotonine | 48.46 | 4 | 86, |
| 45 | Suberylglycine | 23.30 | 3 | |
| 46 | Threonic acid | 20.50 | 4 | 117, 205, 220, |
| 47 | Threonic acid-1,4-lactone | 15.92 | 2 | 101, 116, 131, |
| 48 | Tryptamine | 42.90 | 3 | 86, 100, |
Base peak of each compound is represented with bold characters. RT, retention time; TMS, trimethylsilylation; MEOX, methoxylamine hydrochloride.
Fig 2Relative levels of major metabolites of L. paucicostata cultivated under various ethephon concentrations at day 35.
The suggested pathway of metabolites was expressed in accordance with the KEGG database (http://www.genome.jp/kegg/). Data are means and error bars indicate SD for nine measurements (n = 9, 3 biological replicates and 3 technical replicates). Mann-Whitney test (p < 0.05) was conducted to obtain significant differences between the control and ethephon-treated groups. Significant differences for each ethephon treatment group are indicated by an asterisk.
Fig 3PCA-derived score plots including QC samples.
Treatment with 0.05, 0.1, 0.2, 0.5, and 1 mM ethephon and quality control (QC), are represented by ○, ■ (black), ▲, ▼, ◆, ●, and ■ (orange), respectively.
Production of GABA, caffeic acid, and ferulic acid in L. paucicostata culture under various concentrations of ethephon.
| Compounds (mg/L) | Control | 0.05 mM | 0.1 mM | 0.2 mM | 0.5 mM | 1 mM |
|---|---|---|---|---|---|---|
| γ-Aminobutyric acid (GABA) | 1.655 ± 0.551 | 3.101 ± 0.808 | 2.296 ± 0.789 | 3.394 ± 0.895 | 5.041 ± 1.373 | 1.599 ± 0.589 |
| Caffeic acid | 0.270 ± 0.003 | 0.255 ± 0.013 | 0.233 ± 0.013 | 0.270 ± 0.009 | 0.225 ± 0.036 | ND |
| Ferulic acid | 0.432 ± 0.077 | 0.592 ± 0.033 | 0.600 ± 0.084 | 0.640 ± 0.071 | 0.571 ± 0.024 | 0.129 ± 0.037 |
Data are means ± SD for nine measurements (three biological and experimental replicates).
* denotes significant differences (p < 0.05) between control and ethephon treatment groups (0.05, 0.1, 0.2, 0.5, and 1 mM) on day 35, based on Mann-Whitney test. ND, not detected.